Ironwood Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05 2021 - 7:30AM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused
healthcare company, will provide a corporate overview during a
presentation and Q&A session at the 39th Annual J.P. Morgan
Healthcare Conference on Monday, January 11, 2021 at 5:20 p.m.
Eastern Time.
A live webcast of Ironwood’s presentation will be accessible
through the Investors section of the company’s website at
www.ironwoodpharma.com. To access the webcast, please log on to the
Ironwood website approximately 15 minutes prior to the start time
to ensure adequate time for any software downloads that may be
required. A replay of the webcast will be available on Ironwood’s
website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused
healthcare company dedicated to creating medicines that make a
difference for patients living with GI diseases. We discovered,
developed and are commercializing linaclotide, the U.S. branded
prescription market leader for adults with irritable bowel syndrome
with constipation (IBS-C) or chronic idiopathic constipation
(CIC).
Ironwood was founded in 1998 and is headquartered in Boston,
Mass. For more information, please visit our website at
www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005187/en/
Investor and Media Relations Meredith Kaya, 617-374-5082 Vice
President, Strategy, Investor Relations and Corporate
Communications mkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jul 2023 to Jul 2024